Viewing Study NCT03698994

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2026-02-21 @ 2:54 PM
Study NCT ID: NCT03698994
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-03
First Post: 2018-10-05
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Malignant Solid Neoplasm View
None Recurrent Ependymal Tumor View
None Recurrent Ewing Sarcoma View
None Recurrent Glioma View
None Recurrent Hepatoblastoma View
None Recurrent Histiocytic and Dendritic Cell Neoplasm View
None Recurrent Langerhans Cell Histiocytosis View
None Recurrent Malignant Germ Cell Tumor View
None Recurrent Malignant Solid Neoplasm View
None Recurrent Medulloblastoma View
None Recurrent Neuroblastoma View
None Recurrent Non-Hodgkin Lymphoma View
None Recurrent Osteosarcoma View
None Recurrent Peripheral Primitive Neuroectodermal Tumor View
None Recurrent Primary Malignant Central Nervous System Neoplasm View
None Recurrent Rhabdoid Tumor View
None Recurrent Rhabdomyosarcoma View
None Recurrent Soft Tissue Sarcoma View
None Refractory Ependymoma View
None Refractory Ewing Sarcoma View
None Refractory Glioma View
None Refractory Hepatoblastoma View
None Refractory Histiocytic and Dendritic Cell Neoplasm View
None Refractory Langerhans Cell Histiocytosis View
None Refractory Malignant Germ Cell Tumor View
None Refractory Malignant Solid Neoplasm View
None Refractory Medulloblastoma View
None Refractory Neuroblastoma View
None Refractory Non-Hodgkin Lymphoma View
None Refractory Osteosarcoma View
None Refractory Peripheral Primitive Neuroectodermal Tumor View
None Refractory Primary Malignant Central Nervous System Neoplasm View
None Refractory Rhabdoid Tumor View
None Refractory Rhabdomyosarcoma View
None Refractory Soft Tissue Sarcoma View
None Wilms Tumor View
Keywords: